Spermidine plus resistance exercise protected aging hearts and their mitochondria — in lab models

The aging heart does not fail all at once. Its mitochondria — the organelles that supply nearly all of the heart muscle's energy — gradually lose their quality control: damaged units are cleared more slowly (mitophagy), new ones are built more slowly (biogenesis), and cell death creeps up. A study published October 17, 2026 in Scientific Reports (Yang, Sun, Cheng and colleagues, Harbin Sport University) asked whether two autophagy-promoting interventions work better together than alone: spermidine, a polyamine present in foods such as wheat germ and aged cheese, and resistance exercise.

Rats were aged with six weeks of daily D-galactose injections — a standard accelerated-aging model, verified by senescence genes p53, p21 and p16 and by tissue staining — then assigned for eight weeks to resistance exercise alone, exercise plus vehicle, or spermidine plus exercise.

What did the combination do to the heart's mitochondria?

The combined intervention significantly improved pathological heart structure, mitochondrial shape abnormalities and functional impairment. Myocardial ATP, citrate synthase, cytochrome c oxidase subunit I (COX I) and mitochondrial membrane potential all rose. Mechanistically, the treatment activated the AMPK-SIRT1-PGC-1alpha signaling pathway — upregulating p-AMPK, SIRT1, PGC-1alpha, NRF1 and TFAM to promote mitochondrial biogenesis — while enhanced mitophagy was confirmed by a higher LC3B-II/LC3B-I ratio and lower p62, and apoptosis was suppressed (Bcl-2 up, Bax down).

Why pair a molecule with exercise at all?

Both spermidine and resistance exercise are known to induce autophagy, the cell's recycling system, and both have shown cardioprotective anti-aging effects separately. The study's premise is that a nutritional signal and a mechanical signal converging on the same energy-sensing pathway (AMPK-SIRT1-PGC-1alpha) could reinforce each other — a design increasingly common in mitochondrial aging research, where single interventions tend to produce modest effects.

What are the limits readers should keep in view?

Three, plainly. This is a rat study using a chemically induced aging model, not natural human aging. The design compared the combination against exercise alone, so it cannot isolate what spermidine adds in sedentary animals — and there was no spermidine-only arm in the intervention phase described. And doses used in published animal studies are research doses, not advice: nothing here establishes a human dose, a human benefit, or safety in people with heart disease. The honest takeaway is a well-mapped mechanism in animals that now needs human testing.

Where the evidence stands

• Established: Age-related heart decline is linked to dysregulated mitophagy, impaired mitochondrial biogenesis and increased apoptosis, and the AMPK-SIRT1-PGC-1alpha pathway is a central regulator of mitochondrial renewal.
• Preliminary: In D-galactose-aged rats (Scientific Reports, Oct 17, 2026), eight weeks of spermidine plus resistance exercise improved heart structure and mitochondrial function, raised ATP and membrane potential, activated AMPK-SIRT1-PGC-1alpha signaling, increased mitophagy markers and reduced apoptosis markers.
• Absent: Human evidence that spermidine, alone or with exercise, improves heart or mitochondrial outcomes, and any established human dose for this purpose.